INS and Hypoglycemia: We next investigated whether inhibition of specific serotonin receptor subtypes could block serotonin-induced hypoglycemia, selecting inhibitors of 5-HTR3 and 5-HTR2, given their demonstrated role in metabolism and insulin secretion (17–19).